{"nct_id":"NCT06890884","title":"A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-04-11","start_date_type":"ACTUAL","primary_completion_date":"2027-12-13","primary_completion_date_type":"ESTIMATED","completion_date":"2032-12-16","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}